Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May 22;17(5):e84596.
doi: 10.7759/cureus.84596. eCollection 2025 May.

Rapidly Evolving Cervical Dermatofibrosarcoma Protuberans With Deep Muscle Infiltration: A Rare and Aggressive Presentation

Affiliations
Case Reports

Rapidly Evolving Cervical Dermatofibrosarcoma Protuberans With Deep Muscle Infiltration: A Rare and Aggressive Presentation

Oumaima Bouraqqadi et al. Cureus. .

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade sarcoma that typically presents as a slow-growing cutaneous nodule or plaque. We report a highly unusual case of DFSP involving the neck, which demonstrated rapid enlargement, necrosis, and deep muscle infiltration. A 45-year-old man presented with a large, bleeding cervical tumor that had evolved over two years. Imaging revealed extensive involvement of the neck and shoulder musculature without distant metastasis. Histopathologic evaluation confirmed the diagnosis of DFSP. Given the tumor's inoperability, treatment with imatinib was initiated, resulting in marked tumor regression. This case highlights an atypical presentation of DFSP in terms of both location and clinical behavior. It underscores the importance of repeated histologic assessment in the face of rapid progression, the role of imaging in surgical planning, and the value of targeted therapy when surgical options are limited.

Keywords: darier–ferrand dermatofibrosarcoma; dermatofibrosarcoma protuberans; imatinib mesylate; imatinib therapy; oncodermatology.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Clinical presentation of a well-defined subcutaneous tumor (~10 cm) in the basicervical region, with erythematous-violaceous overlying skin (yellow arrows). A second, superimposed angiomatous lesion, ulcerated and highly hemorrhagic, measuring approximately 6 cm is also visible (yellow asterisk). (A) Lateral view. (B) Frontal view
Figure 2
Figure 2. DFSP. (A) Tumor proliferation composed of spindle-shaped cells showing mild to moderate nuclear atypia (H&E, ×400). (B) Immunohistochemistry showing intense and diffuse positivity for CD34, consistent with DFSP
H&E: hematoxylin and eosin, DFSP: dermatofibrosarcoma protuberans
Figure 3
Figure 3. Helical CT scan in axial (A) and coronal (B) planes after iodinated contrast injection, showing an exophytic lesion (yellow asterisk) arising from the right posterior cervical soft tissues, with ill-defined, irregular margins. The lesion invades the right longus colli muscle (red arrow) and the ipsilateral trapezius muscle (yellow arrow)
CT: computed tomography
Figure 4
Figure 4. MRI showing a well-defined, lobulated mass (yellow asterisk) arising from the right basi-cervical soft tissues. The lesion appears isointense on T1-weighted images (A, B), hyperintense on T2/STIR sequences (C, D), and shows heterogeneous enhancement after contrast (E, F). It invades the ipsilateral longus colli (orange arrow) and trapezius muscles (red arrow)
MRI: magnetic resonance imaging
Figure 5
Figure 5. Marked increase in the size of the angiomatous lesion one month after the initial consultation. The lesion became largely necrotic and measured approximately 15 cm in diameter. (A) Lateral view. (B) Posterior view
Figure 6
Figure 6. Helical CT acquisition in axial (A) and sagittal (B) planes showing significant reduction in the size of the mass (yellow asterisk) arising from the right basi-cervical soft tissues, still in close contact with the ipsilateral trapezius muscle
CT: computed tomography
Figure 7
Figure 7. Marked reduction of the subcutaneous tumor four months after initiation of imatinib therapy (arrows), with complete regression of the angiomatous component (asterisk). (A) Posterior view. (B) Lateral view

Similar articles

References

    1. Dermatofibrosarcoma protuberans: an updated review of the literature. Jozwik M, Bednarczuk K, Osierda Z. Cancers (Basel) 2024;16:3124. - PMC - PubMed
    1. Giant ulcerative dermatofibroma. Karlidag T, Keles E, Orhan I, Kaplama ME, Cobanoglu B. Case Rep Otolaryngol. 2013;2013:254787. - PMC - PubMed
    1. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Cancer. 2004;100:1008–1016. - PubMed
    1. Dermatofibrosarcoma protuberans: what is this? Vitiello GA, Lee AY, Berman RS. Surg Clin North Am. 2022;102:657–665. - PubMed
    1. The epidemiology of dermatofibrosarcoma protuberans incidence, metastasis, and death among various population groups: a surveillance, epidemiology, and end results database analysis. Maghfour J, Genelin X, Olson J, Wang A, Schultz L, Blalock TW. J Am Acad Dermatol. 2024;91:826–833. - PubMed

Publication types

LinkOut - more resources